91099-12-6 Usage
Derivative of isobenzofuran carboxamide
The compound is a modified version of the parent compound isobenzofuran carboxamide.
Organic intermediate
The compound is commonly used as an intermediate in the synthesis of other compounds, particularly in the pharmaceutical and agrochemical industries.
Anti-inflammatory and analgesic properties
The compound has been shown to have potential therapeutic benefits, specifically in reducing inflammation and pain.
Potential use in treatment
The compound has been studied for its potential use in treating various diseases and conditions.
Hazardous if not handled properly
The compound may pose a risk to human health or the environment if not handled or disposed of properly, so it is important to follow proper safety precautions.
Check Digit Verification of cas no
The CAS Registry Mumber 91099-12-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,9 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 91099-12:
(7*9)+(6*1)+(5*0)+(4*9)+(3*9)+(2*1)+(1*2)=136
136 % 10 = 6
So 91099-12-6 is a valid CAS Registry Number.
91099-12-6Relevant academic research and scientific papers
Central Nervous System Active Compounds. XIV On the Cyclization of N-Acyl-N'-arylureas
Heinicke, Grant,Hung, Tran V.,Prager, Rolf H.,Ward, A. David
, p. 831 - 844 (2007/10/02)
The cyclization of N-acyl-N'-arylureas in polyphosphoric acid has been reinvestigated.The product is not only the 4-substituted quinazolin-2(1H)-one as reported, but also contains the 2-acylaniline in major proportions.Two minor products have also been isolated.At 80 deg, an intermediate has been detected, the properties of which are consistent with it being the corresponding 2-acylphenylurea.Acyl ureas with strongly electron-withdrawing acyl groups from major amount of the corresponding anilide by the formal loss of cyanic acid.The application of this reaction tothe synthesis of quinazolinylphthalides has been investigated.
